Skip to content

CorMedix CRMD Deferred taxes

Deferred taxes at other companies

TFX
TeleflexTFX
-$12.71M-11,669%
Baxter International logo
Baxter InternationalBAX
$19.25M+129%
Pfizer logo
PfizerPFE
Haemonetics logo
HaemoneticsHAE
Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's deferred taxes?
CorMedix (CRMD) reported deferred taxes of $12.96M in Q1 2026.
What does deferred taxes mean?
Reflects the change in deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax bases of assets and liabilities. This metric provides insight into future tax obligations or benefits and the company's effective tax planning strategy.